Endovascular Therapy for Acute Ischemic Stroke with Mild Deficits

About 1 in 10 patients treated with endovascular therapy had minor deficits at presentation in a registry study.

In 2015, several published clinical trials demonstrated the value of mechanical thrombectomy (MT) for patients with acute ischemic stroke and evidence of large-vessel occlusion (LVO). These trials enrolled primarily patients with moderate-to-severe strokes; patients with mild deficits at presentation were either excluded or underrepresented. Some patients presenting with mild deficits, defined as an NIH Stroke Scale score of ≤5, have evidence of an LVO, and the optimal treatment of these patients is uncertain. These authors evaluated a large registry of 4110 patients (median age, 73 years; 50% women) who underwent MT for acute stroke in either Florida or Puerto Rico from 2010 through 2018. In this group, 11% had an NIH Stroke Scale score of…

Reviewing Author

Seemant Chaturvedi, MD

Disclosures

Consultant/Advisory BoardBayer Pharmaceuticals; Novartis

Grant/Research SupportNational Institute of Neurological Disorders and Stroke

Editorial BoardsNeurology; Stroke

Seemant Chaturvedi, MD

Disclosures

Consultant/Advisory BoardBayer Pharmaceuticals; Novartis

Grant/Research SupportNational Institute of Neurological Disorders and Stroke

Editorial BoardsNeurology; Stroke

Endovascular Therapy for Acute Ischemic Stroke with Mild Deficits

Topics

Reviewing Author